Australian antiviral drug development company, Island Pharmaceuticals (ASX:ILA), has signed an agreement to acquire the galidesivir antiviral program from US-based BioCryst Pharmaceuticals. …
Latest Video
New Stories
-
Amplia Therapeutics secures ethics approval for pancreatic cancer trial
July 30, 2025 - - Australian Biotech -
World-first study uses DNA to investigate who develops MS and why
July 30, 2025 - - Latest News -
Plenty going on behind the scenes, but the industry so far is mostly favouring public silence
July 30, 2025 - - Latest News -
'No data means no prospect of access to trials or funded medicines'
July 30, 2025 - - Latest News -
The problem with the minister's statement is that it's entirely accurate
July 30, 2025 - - Latest News -
Government moves on general co-pay as safety net gets further out of reach
July 29, 2025 - - Latest News -
'For these families, genomics is not a luxury—it’s the only viable path'
July 29, 2025 - - Latest News